Direct Oral Anticoagulants versus Vitamin K Antagonists in Cirrhotic Patients with Atrial Fibrillation: Update of Systematic Review and Meta-Analysis
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Direct Oral Anticoagulants versus Vitamin K Antagonists in Cirrhotic Patients with Atrial Fibrillation: Update of Systematic Review and Meta-Analysis
Authors
Keywords
-
Journal
American Journal of Cardiovascular Drugs
Volume 23, Issue 6, Pages 683-694
Publisher
Springer Science and Business Media LLC
Online
2023-08-28
DOI
10.1007/s40256-023-00598-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Comparative Effectiveness and Safety of Direct Oral Anticoagulants and Warfarin in Patients With Atrial Fibrillation and Chronic Liver Disease: A Nationwide Cohort Study
- (2023) Oluwadolapo D. Lawal et al. CIRCULATION
- Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation
- (2022) Seo Yeon Yoo et al. KOREAN JOURNAL OF INTERNAL MEDICINE
- Haemostatic alterations and management of haemostasis in patients with cirrhosis
- (2022) Ton Lisman et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines on prevention and management of bleeding and thrombosis in patients with cirrhosis
- (2022) Erica Villa et al. JOURNAL OF HEPATOLOGY
- Review article: diagnosis, pathophysiology and management of atrial fibrillation in cirrhosis and portal hypertension
- (2022) Bert Vandenberk et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Comparison of the Efficacy and Safety of Direct Oral Anticoagulants and Vitamin K Antagonists in Patients with Atrial Fibrillation and Concomitant Liver Cirrhosis: A Systematic Review and Meta-Analysis
- (2021) Zhi-Yan Lee et al. American Journal of Cardiovascular Drugs
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Safety of direct oral anticoagulants in patients with advanced liver disease
- (2021) Georg Semmler et al. LIVER INTERNATIONAL
- Mortality and hepatic decompensation in patients with cirrhosis and atrial fibrillation treated with anticoagulation
- (2020) Marina Serper et al. HEPATOLOGY
- 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS)
- (2020) Gerhard Hindricks et al. EUROPEAN HEART JOURNAL
- Effectiveness and Safety of Non–Vitamin K Antagonist Oral Anticoagulant and Warfarin in Cirrhotic Patients With Nonvalvular Atrial Fibrillation
- (2019) Hsin‐Fu Lee et al. Journal of the American Heart Association
- Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis
- (2019) Carlos Noronha Ferreira et al. DIGESTIVE DISEASES AND SCIENCES
- Safety of Direct Oral Anticoagulants in Patients with Cirrhosis: A Systematic Review and Meta-analysis
- (2019) Kamolyut Lapumnuaypol et al. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE
- Direct Oral Anticoagulants in Patients With Atrial Fibrillation and Liver Disease
- (2019) So-Ryoung Lee et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Safety of direct oral anticoagulants vs warfarin in patients with chronic liver disease and atrial fibrillation
- (2018) Pavel Goriacko et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Incidence of bleeding in patients with atrial fibrillation and advanced liver fibrosis on treatment with vitamin K or non-vitamin K antagonist oral anticoagulants
- (2018) Daniele Pastori et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Oral Anticoagulation in Patients With Liver Disease
- (2018) Arman Qamar et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Management of Coagulation and Anticoagulation in Liver Transplantation Candidates
- (2018) Patrick Northup et al. LIVER TRANSPLANTATION
- Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference
- (2018) C. K. Argo et al. THROMBOSIS AND HAEMOSTASIS
- Direct oral anticoagulants in patients with liver cirrhosis: A systematic review
- (2018) Evert Willian Hoolwerf et al. THROMBOSIS RESEARCH
- The efficacy and safety of direct oral anticoagulants vs traditional anticoagulants in cirrhosis
- (2017) Justine Hum et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Risks Versus Benefits of Anticoagulation for Atrial Fibrillation in Cirrhotic Patients
- (2017) Jonggi Choi et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY
- Dissociation between the pharmacokinetics and pharmacodynamics of once-daily rivaroxaban and twice-daily apixaban: a randomized crossover study
- (2017) R. Kreutz et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Cirrhosis is a risk factor for atrial fibrillation: A nationwide, population-based study
- (2017) HyunJung Lee et al. LIVER INTERNATIONAL
- Liver Cirrhosis in Patients With Atrial Fibrillation: Would Oral Anticoagulation Have a Net Clinical Benefit for Stroke Prevention?
- (2017) Ling Kuo et al. Journal of the American Heart Association
- Efficacy and safety of anticoagulation in more advanced portal vein thrombosis in patients with liver cirrhosis
- (2016) Hui Chen et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Systemic inflammation in decompensated cirrhosis: Characterization and role in acute-on-chronic liver failure
- (2016) Joan Clària et al. HEPATOLOGY
- Attenuation of the unfolded protein response and endoplasmic reticulum stress after mechanical unloading in dilated cardiomyopathy
- (2015) Estibaliz Castillero et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- CHA2DS2-VASc had better discrimination than CHADS2for predicting risk for thromboembolism in atrial fibrillation
- (2013) John A. Cairns ANNALS OF INTERNAL MEDICINE
- Effect of hepatic impairment on the pharmacokinetics and pharmacodynamics of a single dose of rivaroxaban, an oral, direct Factor Xa inhibitor
- (2013) Dagmar Kubitza et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Atrial fibrillation
- (2011) Gregory YH Lip et al. LANCET
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Systematic review: portal vein thrombosis in cirrhosis
- (2009) E. A. TSOCHATZIS et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started